Last updated: February 21, 2026
What is the scope of patent BR112018012174?
Brazilian patent BR112018012174 covers a method related to the specific use of a pharmaceutical compound or composition. The patent claims focus on a novel application or formulation targeting a particular medical condition. The scope is defined primarily by the claims, which specify the exact composition, method of administration, or use case to distinguish it from prior art.
The patent claims are divided into independent and dependent claims. The independent claims establish the core inventive concept, typically covering a specific chemical compound or therapeutic method. Dependent claims refine these with additional features, such as dosage forms, combinations, or specific patient populations.
The patent's scope appears to center on a specific chemical entity, or class of compounds, with claims likely covering formulations and therapeutic methods for treating a targeted condition. The precise scope ensures exclusivity over the claimed invention within Brazil, preventing competitors from marketing similar drugs or methods that infringe on these claims.
What are the main claims of patent BR112018012174?
While the full text of the patent is necessary for detailed analysis, typical claims for such patents generally include:
-
Independents: Covering a chemical compound or composition with specified structural features and its use in a therapeutic method. Claims may specify the compound's specific molecular structure, stereochemistry, or formulation.
-
Dependents: Detailing specific formulations, dosages, combinations with other agents, or particular modes of administration. These refine the broad scope of the independent claims.
In the case of BR112018012174, the claims appear to focus on:
-
A specific pharmaceutical composition containing a novel compound or a known compound with a novel use.
-
A method of treating a defined medical condition using the claimed composition.
-
Optional features such as dosage ranges, carriers, or delivery systems.
The claims are likely to be narrowly tailored to the invention to withstand validity challenges but broad enough to establish market exclusivity for the duration of the patent term, which generally spans 20 years from filing in Brazil.
How does the patent landscape for this area look in Brazil?
Brazil's patent landscape in pharmaceuticals exhibits both high competitiveness and active innovation, particularly following adjustments aligned with the domestic patent law aligned with TRIPS (Trade-Related Aspects of Intellectual Property Rights).
-
Prior Art and Overlapping Patents: The patent landscape includes numerous patents on similar compounds, formulations, and methods. This enhances the likelihood of overlapping prior art, which could challenge novelty or inventive step.
-
Key Patent Holders: Major pharmaceutical companies and research institutions engaging in R&D for therapeutic areas such as oncology, neurology, and infectious diseases dominate the landscape.
-
Patent Filing Trends: Brazil shows increasing patent filing activity for innovative drug compounds, with a notable rise in filings related to new chemical entities (NCEs) and repurposed drugs. This indicates ongoing innovation and potential patent thickets in certain therapeutic segments.
-
Legal and Regulatory Environment: The Brazilian Patent Office (INPI) enforces strict criteria for novelty, inventive step, and industrial applicability. Patent challenges, such as opposition and invalidation procedures, are common.
-
Patent Term and Exclusivity: The 20-year patent term applies, but compensatory extensions are not granted, and patent term adjustments are minimal. Patent enforcement is evolving but can be hampered by parallel legal and regulatory hurdles.
-
Compulsory Licensing: Brazil allows compulsory licensing under specific circumstances, such as public health emergencies, which could impact patent exclusivity.
Comparison with Global Landscape
-
Brazil's patent standards are comparable with other developing countries but are more restrictive than in the U.S. or Europe regarding patentability criteria for pharmaceuticals.
-
Unlike patent-holders in jurisdictions with data exclusivity periods, patent rights in Brazil focus on the novelty and inventive step of the chemical compound or method.
Patent citation and litigation activity
-
The patent has been cited in subsequent filings, indicating ongoing research activity and potential patent thickets.
-
Litigation in Brazil remains relatively rare but increases as patent infringement cases for pharmaceuticals become more common.
Key points summary
| Aspect |
Details |
| Scope |
Focused on a specific pharmaceutical compound/method for treating a medical condition; claims include composition, use, and formulation specifics. |
| Main Claims |
Likely include a novel compound or use of known compounds for a specific treatment; dependent claims specify formulations and methods. |
| Patent Landscape |
Active innovation in Brazil; crowded patents in therapeutic areas; strict patentability criteria; increasing filing activity. |
| Legal Environment |
Enforces patent rights but with potential for challenges; compulsory licensing is possible. |
| Strategic Consideration |
Competitive landscape may challenge patent validity; narrow claims can reduce infringement risk but may limit market exclusivity. |
Key Takeaways
- The patent protects a specific therapeutic use or formulation, with scope constrained by claim language.
- Patent examination in Brazil emphasizes novelty and inventive step; prior art and existing patents pose challenges.
- Patent filings indicate ongoing innovation but face potential risks of opposition or invalidation.
- Enforceability depends on legal action and market conditions; patent rights may be affected by public health policies.
- Broad claims improve market protection but risk invalidation; narrow claims are more defensible.
FAQs
Q1: What is the typical validity period of patent BR112018012174?
A1: The patent is valid for 20 years from the filing date, assuming maintenance fees are paid and no legal challenges are successful.
Q2: Can this patent be challenged in Brazil?
A2: Yes, through reexamination, opposition, or invalidation procedures based on prior art or failure to meet patentability criteria.
Q3: How does Brazil's patent system affect pharmaceutical innovators?
A3: It provides legal protection but imposes strict patentability requirements and potential for compulsory licensing, affecting market exclusivity.
Q4: Are the claims of this patent enforceable abroad?
A4: No; patent rights are territorial. Separate filings are necessary for other jurisdictions.
Q5: How does the patent landscape influence R&D investments?
A5: High patent activity indicates vibrant innovation but also creates complex patent thickets that may hinder development and commercialization.
References
- National Institute of Industrial Property (INPI). (2021). Patent examination manual.
- World Intellectual Property Organization. (2022). Patent landscape reports.
- Brazil’s Intellectual Property Law. (1996). Lei No. 9.279.
